You may soon be able to add Oregon to the growing number of states with laws that require drug makers to report and justify price hikes for some medicines.
In a bipartisan vote late Friday, the Oregon Senate overwhelmingly passed such a bill, 25-to-4, just a few days after the same legislation was approved by the House. The legislation, called the Prescription Drug Price Transparency Act, now goes to Gov. Kate Brown, who is expected to sign it.
The bill is fairly similar to what has become law in a few other states. When the price of a medicine rises more than 10 percent, a drug maker must report the reasons to the Oregon Department of Consumer and Business Services, including information about cost of production, marketing and research. Manufacturers face civil penalties of up to $10,000 per day for failing to comply.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
